← Back to Search

Health Maintenance Text Reminders for Preventive Care

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the reminder
Awards & highlights

Study Summary

This trial tests if text messages can help people engage in preventive primary care to stay healthy.

Who is the study for?
This trial is for UCLA Health patients with overdue health maintenance measures like diabetes or cancer screenings, who can receive SMS messages and have not engaged with the My Action Plan initiative. Participants must be registered with UCLA Health's primary care, have an active MyChart status, and birthdays in March or April.Check my eligibility
What is being tested?
The study tests if text message reminders that include anecdotes and action prompts can increase patient involvement in preventive healthcare. It's a randomized trial where some will get these texts as part of UCLA Health's effort to boost completion rates for routine care.See study design
What are the potential side effects?
Since this intervention involves receiving text messages rather than medical treatments, there are no direct physical side effects expected from participating in this clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the reminder
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the reminder for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MyChart letter opened
Secondary outcome measures
Completion rate of one screening/test
Direct scheduling appointment rate
Opening link within SMS Text message
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Control ReminderExperimental Treatment1 Intervention
Eligible, randomized participants will receive a generic text message reminding them to close their outstanding health gap.
Group II: Call-to-action ReminderExperimental Treatment2 Interventions
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap. This message will prompt people to take care of the health gap right away before it slips their mind.
Group III: Anecdote-based ReminderExperimental Treatment2 Interventions
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap. This message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings.
Group IV: Holdout Condition: No reminderActive Control1 Intervention
Eligible, randomized participants will receive no text message reminder.

Find a Location

Who is running the clinical trial?

The David Geffen School of MedicineUNKNOWN
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,252,851 Total Patients Enrolled
UCLA Department of MedicineUNKNOWN
3 Previous Clinical Trials
44,898 Total Patients Enrolled

Media Library

Call-to-action Reminder Clinical Trial Eligibility Overview. Trial Name: NCT05791942 — N/A
Cancer Research Study Groups: Call-to-action Reminder, Holdout Condition: No reminder, Control Reminder, Anecdote-based Reminder
Cancer Clinical Trial 2023: Call-to-action Reminder Highlights & Side Effects. Trial Name: NCT05791942 — N/A
Call-to-action Reminder 2023 Treatment Timeline for Medical Study. Trial Name: NCT05791942 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being welcomed into this experiment?

"Data from clinicaltrials.gov reveals that, although first posted on March 23rd 2023 and most recently updated on May 8th of the same year, recruitment for this trial is not being sought at present. Conversely, 699 other trials are currently looking to enroll patients."

Answered by AI
~11520 spots leftby Apr 2025